Surfactant protein-A inhibits Mycoplasma-induced dendritic cell maturation through regulation of HMGB-1 cytokine activity

Journal of Immunology

Volumn 185, Issue 7, 2010, Pages 3884-3894

  Ledford, Julie G ^a   Lo, Bernice ^a   Kislan, Michele M ^a   Thomas, Joseph M ^a   Evans, Katherine ^a   Cain, Derek W ^a   Kraft, Monica ^a   Williams, Kristi L ^a   Wright, Jo Rae ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCYRRHIZIC ACID; HIGH MOBILITY GROUP B1 PROTEIN; SURFACTANT PROTEIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE COURSE; LUNG; LUNG INFECTION; LYMPHATIC DRAINAGE; LYMPHOCYTE COUNT; MALE; MEDIASTINUM LYMPH NODE; MOUSE; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL; C57BL MOUSE; CELL DIFFERENTIATION; CELL SEPARATION; CYTOLOGY; FLOW CYTOMETRY; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; MYCOPLASMOSIS; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL SEPARATION; DENDRITIC CELLS; FLOW CYTOMETRY; HMGB1 PROTEIN; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MYCOPLASMA INFECTIONS; MYCOPLASMA PNEUMONIAE; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A;

EID: 77958130241     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000387     Document Type: Article

References (35)

1. Waites, K. B., and D. F. Talkington. 2004. Mycoplasma pneumoniae and its role as a human pathogen. Clin. Microbiol. Rev. 17:697-728, table of contents.
2. Martin, R. J., M. Kraft, H. W. Chu, E. A. Berns, and G. H. Cassell. 2001. A link between chronic asthma and chronic infection. J. Allergy Clin. Immunol. 107:595-601.
3. Kraft, M., G. H. Cassell, J. E. Henson, H. Watson, J. Williamson, B. P. Marmion, C. A. Gaydos, and R. J. Martin. 1998. Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am. J. Respir. Crit. Care Med. 158:998-1001.
4. Kannan, T. R., D. Provenzano, J. R. Wright, and J. B. Baseman. 2005. Identification and characterization of human surfactant protein A binding protein of Mycoplasma pneumoniae. Infect. Immun. 73:2828-2834.
5. Piboonpocanun, S., H. Chiba, H. Mitsuzawa, W. Martin, R. C. Murphy, R. J. Harbeck, and D. R. Voelker. 2005. Surfactant protein A binds Mycoplasma pneumoniae with high affinity and attenuates its growth by recognition of disaturated phosphatidylglycerols. J. Biol. Chem. 280:9-17.
6. Ledford, J. G., H. Goto, E. N. Potts, S. Degan, H. W. Chu, D. R. Voelker, M. E. Sunday, G. J. Cianciolo, W. M. Foster, M. Kraft, and J. R. Wright. 2009. SP-A preserves airway homeostasis during Mycoplasma pneumoniae infection in mice. J. Immunol. 182:7818-7827.
7. Wright, J. R. 2005. Immunoregulatory functions of surfactant proteins. Nat. Rev. Immunol. 5:58-68.
8. Brinker, K. G., H. Garner, and J. R. Wright. 2003. Surfactant protein A modulates the differentiation of murine bone marrow-derived dendritic cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 284: L232-L241.
9. Telusma, G., S. Datta, I. Mihajlov, W. Ma, J. Li, H. Yang, W. Newman, B. T. Messmer, B. Minev, I. G. Schmidt-Wolf, et al. 2006. Dendritic cell activating peptides induce distinct cytokine profiles. Int. Immunol. 18:1563-1573.
10. Korfhagen, T. R., M. D. Bruno, G. F. Ross, K. M. Huelsman, M. Ikegami, A. H. Jobe, S. E. Wert, B. R. Stripp, R. E. Morris, S. W. Glasser, et al. 1996. Altered surfactant function and structure in SP-A gene targeted mice. Proc. Natl. Acad. Sci. USA 93:9594-9599.
11. Sitia, G., M. Iannacone, S. Müller, M. E. Bianchi, and L. G. Guidotti. 2007. Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice. J. Leukoc. Biol. 81:100-107.
12. Pecora, N. D., S. A. Fulton, S. M. Reba, M. G. Drage, D. P. Simmons, N. J. Urankar-Nagy, W. H. Boom, and C. V. Harding. 2009. Mycobacterium bovis BCG decreases MHC-II expression in vivo on murine lung macrophages and dendritic cells during aerosol infection. Cell Immunol. 254:94-104.
13. Lin, K. L., Y. Suzuki, H. Nakano, E. Ramsburg, and M. D. Gunn. 2008. CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenzainduced pulmonary immune pathology and mortality. J. Immunol. 180:2562-2572.
14. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1693-1702.
15. Brinker, K. G., E. Martin, P. Borron, E. Mostaghel, C. Doyle, C. V. Harding, and J. R. Wright. 2001. Surfactant protein D enhances bacterial antigen presentation by bone marrow-derived dendritic cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 281: L1453-L1463.
16. McIntosh, J. C., S. Mervin-Blake, E. Conner, and J. R. Wright. 1996. Surfactant protein A protects growing cells and reduces TNF-alpha activity from LPS-stimulated macrophages. Am. J. Physiol. 271: L310-L319.
17. Cartner, S. C., J. W. Simecka, J. R. Lindsey, G. H. Cassell, and J. K. Davis. 1995. Chronic respiratory mycoplasmosis in C3H/HeN and C57BL/6N mice: lesion severity and antibody response. Infect. Immun. 63:4138-4142.
18. Cook, D. N., and K. Bottomly. 2007. Innate immune control of pulmonary dendritic cell trafficking. Proc. Am. Thorac. Soc. 4:234-239.
19. Kirby, A. C., J. G. Raynes, and P. M. Kaye. 2006. CD11b regulates recruitment of alveolar macrophages but not pulmonary dendritic cells after pneumococcal challenge. J. Infect. Dis. 193:205-213.
20. Lambrecht, B. N., J. B. Prins, and H. C. Hoogsteden. 2001. Lung dendritic cells and host immunity to infection. Eur. Respir. J. 18:692-704.
21. McWilliam, A. S., S. Napoli, A. M. Marsh, F. L. Pemper, D. J. Nelson, C. L. Pimm, P. A. Stumbles, T. N. Wells, and P. G. Holt. 1996. Dendritic cells are recruited into the airway epithelium during the inflammatory response to a broad spectrum of stimuli. J. Exp. Med. 184:2429-2432.
22. Sozzani, S., F. Sallusto, W. Luini, D. Zhou, L. Piemonti, P. Allavena, J. Van Damme, S. Valitutti, A. Lanzavecchia, and A. Mantovani. 1995. Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. J. Immunol. 155:3292-3295.
23. Vermaelen, K. Y., I. Carro-Muino, B. N. Lambrecht, and R. A. Pauwels. 2001. Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes. J. Exp. Med. 193:51-60.
24. Wilson, N. S., D. El-Sukkari, G. T. Belz, C. M. Smith, R. J. Steptoe, W. R. Heath, K. Shortman, and J. A. Villadangos. 2003. Most lymphoid organ dendritic cell types are phenotypically and functionally immature. Blood 102:2187-2194.
25. Andersson, U., H. Wang, K. Palmblad, A. C. Aveberger, O. Bloom, H. Erlandsson-Harris, A. Janson, R. Kokkola, M. Zhang, H. Yang, and K. J. Tracey. 2000. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J. Exp. Med. 192:565-570.
26. Erlandsson Harris, H., and U. Andersson. 2004. Mini-review: The nuclear protein HMGB1 as a proinflammatory mediator. Eur. J. Immunol. 34:1503-1512.
27. Dumitriu, I. E., P. Baruah, B. Valentinis, R. E. Voll, M. Herrmann, P. P. Nawroth, B. Arnold, M. E. Bianchi, A. A. Manfredi, and P. Rovere-Querini. 2005. Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J. Immunol. 174:7506-7515.
28. Girard, J. P. 2007. A direct inhibitor of HMGB1 cytokine. Chem. Biol. 14:345-347.
29. Borron, P., F. X. McCormack, B. M. Elhalwagi, Z. C. Chroneos, J. F. Lewis, S. Zhu, J. R. Wright, V. L. Shepherd, F. Possmayer, K. Inchley, and L. J. Fraher. 1998. Surfactant protein A inhibits T cell proliferation via its collagen-like tail and a 210-kDa receptor. Am. J. Physiol. 275: L679-L686.
30. Dumitriu, I. E., P. Baruah, M. E. Bianchi, A. A. Manfredi, and P. Rovere-Querini. 2005. Requirement of HMGB1 and RAGE for the maturation of human plasmacytoid dendritic cells. Eur. J. Immunol. 35:2184-2190.
31. Mollica, L., F. De Marchis, A. Spitaleri, C. Dallacosta, D. Pennacchini, M. Zamai, A. Agresti, L. Trisciuoglio, G. Musco, and M. E. Bianchi. 2007. Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities. Chem. Biol. 14:431-441.
32. Bonaldi, T., F. Talamo, P. Scaffidi, D. Ferrera, A. Porto, A. Bachi, A. Rubartelli, A. Agresti, and M. E. Bianchi. 2003. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J. 22:5551-5560.
33. Shimizu, T., H. Mochizuki, M. Kato, M. Shigeta, A. Morikawa, and T. Hori. 1991. [Immunoglobulin levels, number of eosinophils in the peripheral blood and bronchial hypersensitivity in children with Mycoplasma pneumoniae pneumonia]. Arerugi 40:21-27.
34. Tang, L. F., Y. C. Shi, Y. C. Xu, C. F. Wang, Z. S. Yu, and Z. M. Chen. 2009. The change of asthma-associated immunological parameters in children with Mycoplasma pneumoniae infection. J. Asthma 46:265-269.
35. Maillard-Lefebvre, H., E. Boulanger, M. Daroux, C. Gaxatte, B. I. Hudson, and M. Lambert. 2009. Soluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseases. Rheumatology (Oxford) 48:1190-1196.